Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Randomized, placebo-controlled, phase III trial of sunitinib in combination with prednisone (SU+P) versus prednisone (P) alone in men with progressive metastatic castration-resistant prostate cancer (mCRPC).
PaperCitations, authors & open-access status
Randomized, placebo-controlled, phase III trial of sunitinib in combination with prednisone (SU+P) versus prednisone (P) alone in men with progressive metastatic castration-resistant prostate cancer (mCRPC). is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 56 citations, 2011 year and closed oa status.
56
Citations
2011
Year
closed
OA Status